Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Jun;36(6):922-926.
doi: 10.1111/jdv.18034. Epub 2022 Mar 14.

A new in vitro method to predict in vivo photoprotection of skin hyperpigmentation induced by visible light

Affiliations
Randomized Controlled Trial

A new in vitro method to predict in vivo photoprotection of skin hyperpigmentation induced by visible light

L Duteil et al. J Eur Acad Dermatol Venereol. 2022 Jun.

Abstract

Background: Ultraviolet radiation is the main cause of skin pigmentation, but more recently visible light has been shown to be an important contributor especially in melano-competent subjects. Photoprotection from visible light can improve several hyperpigmentation disorders. Recently, a visible light photoprotection assessment method has been proposed based on in vivo pigmentation; the visible light photoprotection factor (VL-PF) is determined by assessment of the change in colorimetry parameter ITA over several days measured using a chromameter. Although in vivo methods remain the most representative of real life, in vitro methods are more suited to screening sunscreen formulations.

Objective: The aim of this study was to evaluate the correlation between in vivo and in vitro methods in assessing protection against visible light induced pigmentation.

Methods: We first analysed the in vitro protective properties of the 10 commercially available sunscreens using transmission measurements in the visible spectrum. Then, we performed a monocentric, double-blind, randomized controlled study with intra-individual comparisons in 20 healthy subjects and measure the VL-PF in vivo of those sunscreens. The correlation between the VL-PF and the percentage of blocked light was evaluated using the coefficient of determination R2 .

Results: A strong significant correlation was demonstrated between in vivo visible light protection factor and in vitro transmittance measurements, with the highest correlation factor at 420 nm and in the spectrum covering from 400 to 469 nm.

Conclusion: Transmittance measurements were found to be a good predictive tool to evaluate sunscreen visible light photoprotection efficacy and could be used to select formulations for final in vivo testing.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Transmission spectra of the 10 tested sunscreens (A to J).
Figure 2
Figure 2
In vivo evaluation of the protection against VL‐induced pigmentation of 10 tested sunscreens (A to J). (a) The visible protection was calculated with the VL‐PF and (b) the pVL‐PF=(1‐(1/VL‐PF))×100. Bold dashed line corresponds to the minimum protection and the light dashed line to the maximum protection. (c) Eleven photos showing on the right side the exposed areas and on the left side unexposed areas, all of which were previously treated with sunscreen as indicated in Figure 2.
Figure 3
Figure 3
Correlation between the in vivo protection against VL‐induced pigmentation and the amount of VL blocked in vitro by the 10 tested sunscreens. Correlations at 420 nm (a) and between 400 and 469 nm (b).

References

    1. Duteil L, Cardot‐Leccia N, Queille‐Roussel C et al. Differences in visible light‐induced pigmentation according to wavelengths: A clinical and histological study in comparison with UVB exposure. Pigment Cell Melanoma Res 2014; 27: 822–826. - PubMed
    1. Mahmoud BH, Ruvolo E, Hexsel CL et al. Impact of long‐wavelength UVA and visible light on melanocompetent skin. J Invest Dermatol 2010; 130: 2092–2097. - PubMed
    1. Duteil L, Esdaile J, Maubert Y et al. A method to assess the protective efficacy of sunscreens against visible light‐induced pigmentation. Photodermatol Photoimmunol Photomed 2017; 33: 260–266. - PubMed
    1. Boukari F, Jourdan E, Fontas E et al. Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: A prospective randomized comparative trial. J Am Acad Dermatol 2015; 72: 189–190. - PubMed
    1. Castanedo‐Cazares JP, Hernandez‐Blanco D, Carlos‐Ortega B, Fuentes‐Ahumada C, Torres‐Álvarez B. Near‐visible light and UV photoprotection in the treatment of melasma: A double‐blind randomized trial. Photodermatol Photoimmunol Photomed 2014; 30: 35–42. - PubMed

Publication types

Substances

Grants and funding